Laboratory Detection Flashcards
Contemporary micro for CF, what plates
Blood
Chocolate
MacConkey
Burkholderia Cepacia selective agar
Chromagar plates like SAID or pseudomonas ID
- SAID for small colony variants
Fungi plate like Sabouraud agar
For BCC, any gram negs such as stenos or any strange pseudos molecular ID used to confirm as Phenotypic methods are just nnot reliable for these
Conventional micro for CF,
what methods are there
Standard ID on MALDI TOF
Susceptibility testing on VITEK
BD MAX Multiplex PCR
Line probe assays for NTB
Gel electrophoresis for atypical PAs (not done anymore)
AST for CF
Susceptibiltiy testing on P. aeruginosa isolates associated with early an intermittent colonisation only (no chronic) -> EUCAST
Manual susceptibility testing on P. aeruginosa especially mucoid
Manual susceptibility for all organisms on Burkholderia Cepacia Selective agar -> no breakpoints available for BC
AST is often poorly predictive of clinical outcome especialy in the management of P. aeruginosa
Omissions dont really adversely affect short term clinical outcome
There is a lack of correlation between conventional susceptibility test results and the actual therapeutic success especially in chronic infections
Contemporary vs conventional for CF
Based of a crumlin hospital study:
- culture was 82% sensitive while PCR was 93%
- 80 specimens were PCR positive but culture negative, 26 of which were P. aueriginosa => PC has the potential to detect P. aeruginosa earlier than culture
According to a Belfast study it can detect up to 4-17 months earlier
PA targets on BD MAX for CF
16s rRNA
gyrB
ecfX
oprL
Principle of Line probe assays for NTB mycobacterium in CF
Strip of nitrocellulose with probes all along it
Take organism, extract DNA, amplify up
Add DNA to strip
Targets match to specific nucleotides of the organism
Look for colour change along card
BCC targets on the BD Max for CF
hisA
rpsU
recA
16s rRNA
Pros and Cons of Molecular for CF
MALDI Doesnt work for a lot of the NLF GNBs though
MALDI cannot speciate BCC
Molecular methods allow us to detect pseudomonas before traaditional culture can
This can be important in preventing chronic infection
- patient will be molecular positive before they will have a positive culture, this allows us to treat the infection early on to prevent it from ever becoming chronic
- better for the long term treatment of the patient
BD MAX multiplex PCR for CF
PCR detection of:
- Pseudomonas aeruginosa
- Burkholderia cepacia
- Achromobacter xylosoxidans
- Stenotrophomonas maltophilia
Multi-target approach for BCC
species specific targets for PA
Advantages and disadvantages of line probe assays for NTB Myco in CF
It is not a closed system -> risk of infection -> a lot of steps -> not straight forward
Good performance, successfully identifies 92% of MAC and 100% of M. abscessus
Clinical tests for TB
Mantoux tuberculin skin test
Chest X ray
Interferon gamma release assay (IFGRA)
Lab diagnosis of TB
Isolation of MTC (excluding M. bovis BCG) from a clinical specimen e.g. liquid culture positive
OR
Detection of MTC nucleic acid in a clinical specimen
AND
positive microscopy for AFB
i.e. positive liquid culture or NAAT as well as AFB on smear